HNSCC cells with acquired cetuximab resistance display elevated expression of T172-phosphorylated AMPK, S79-phosphorylated ACC1, and ACC1 (Luo et al., 2017). The gene discussed is ACACA; the disease is head and neck squamous cell carcinoma.